Thanks for your post. I'm in a similar situation in Canada — on Firmagon and Erleada, with bone-oligometastatic prostate cancer. My onco team is sticking with that because I'm tolerating it well and it's keeping my PSA undetectable and other bloodwork and tests in a healthy range. The team lead told me there are "lots of other things" to try if this stops working, but also that he's had patients in my situation go many years without any progression.

I don't have the expertise to evaluate the scientific papers that I have skimmed, but my impression is that the 3-pronged approach is still very experimental and based on early research — it might help or it might make you feel worse.

I don't think there's a consensus in oncology yet that metastatic prostate cancer is curable per se, although some researchers believe that oligometastatic prostate cancer might be, and I had curative (rather than palliative) doses of radiation myself.

The thing about ADT and Erleada is that there's really solid research showing its effectiveness in postponing progression (the Titan study). I, too, will be keeping an eye on other options and discussing them with my team.